Cargando…
Understanding the “individual drug reaction” from the perspective of the interaction between probiotics and lovastatin in vitro and in vivo
BACKGROUND: The existence of the gut microbiota produces an “individual drug reaction.” As members of the intestinal microbiota, probiotics, although they have prebiotic functions, may accelerate the degradation of drugs, thereby affecting drug efficacy. Lovastatin is one of the well-recognized lipi...
Autores principales: | Shen, Siyuan, Wang, Jun, Ma, Chenchen, Chen, Yanni, Ding, Hao, Zhang, Jiachao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518969/ https://www.ncbi.nlm.nih.gov/pubmed/37749663 http://dx.doi.org/10.1186/s40168-023-01658-z |
Ejemplares similares
-
Characterization of chitosan/alginate/lovastatin nanoparticles and investigation of their toxic effects in vitro and in vivo
por: Thai, Hoang, et al.
Publicado: (2020) -
Nanoparticles of Lovastatin: Design, Optimization and in vivo Evaluation
por: Gaber, Dalia A
Publicado: (2020) -
Lovastatin Dose-Dependently Potentiates the Pro-inflammatory Activity of Lipopolysaccharide Both In Vitro and In Vivo
por: Zanin, Valentina, et al.
Publicado: (2013) -
Probiotic consumption influences universal adaptive mutations in indigenous human and mouse gut microbiota
por: Ma, Chenchen, et al.
Publicado: (2021) -
In Vivo and in Vitro Study on Drug-Drug Interaction of Lovastatin and Berberine from Pharmacokinetic and HepG2 Cell Metabolism Studies
por: Cui, Hanming, et al.
Publicado: (2016)